Hebei Changshan Biochemical Soars 7.01%, Hits Intraday High of CNY 25.83

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance today, gaining 7.01% and reaching an intraday high of CNY 25.83. This movement stands in contrast to the broader market, as the China Shanghai Composite index has only risen by 1.16% on the same day. Despite today's positive performance, the company has faced considerable challenges over the past year, with a decline of 47.31% in its stock value compared to the market's 18.97% gain. The company's long-term fundamentals appear weak, highlighted by a negative average Return on Capital Employed (ROCE) of 3.59% and a troubling trend in net sales, which have decreased at an annual rate of 20.03% over the last five years. Additionally, Hebei Changshan has reported negative results for the last four consecutive quarters, with a net profit of CNY -322.94 million reflecting a decline of 62.45%. The company remains net-debt free, but its operating cash flow has reached a low of CNY -31.1 million. As a large-cap player in the pharmaceuticals and biotechnology sector, Hebei Changshan's current market cap stands at CNY 34,444 million.